比较髋膝关节置换术后伤口敷料的开标签随机对照试验:研究方案
该研究是一项随机、对照、开标签试验,计划纳入550例全膝或全髋关节置换手术患者,随机分配至5种敷料之一。主要结局为每次更换敷料时皮肤完整性完好的患者百分比,皮肤完整性定义为无 blisters、erosion、erythema、maceration、swelling、wound dehiscence 和 purulent exudates 的复合指标。研究旨在为临床决策提供不同敷料对伤口愈合结果贡献的信息。
要点
- 比较5种敷料在髋膝关节置换术后伤口护理中的效果。
- 主要结局为更换敷料时皮肤完整性完好的患者百分比。
- 次要结局包括首次更换敷料时间、住院天数及满意度等。
核心结论
- 该研究方案旨在比较5种敷料对髋膝关节置换术后手术伤口愈合结果的影响,结果将有助于临床决策。
研究设计与样本
- 随机、对照、开标签试验,计划纳入550例全膝或全髋关节置换手术患者,随机分配至5种敷料之一。
主要发现
- 原文为研究方案,未报告研究结果。
关键数值与推荐
- 主要结局为更换敷料时皮肤完整性完好的患者百分比,皮肤完整性为无 blisters、erosion、erythema、maceration、swelling、wound dehiscence 和 purulent exudates 的复合指标。
- 次要结局包括首次更换敷料时间、各皮肤问题存在/缺失的患者百分比、更换敷料次数、住院天数及护士和患者满意度。
- 计划对糖尿病与非糖尿病患者、BMI>30 或≤30 的患者以及手术类型(髋或膝)进行亚组分析。
临床怎么用
- 研究结果可为临床选择髋膝关节置换术后伤口敷料提供依据,并可能根据患者特征显示哪种敷料效果更好。
局限性
- 原文为研究方案,尚未报告研究结果,无法评估实际效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Surgical wounds are covered to prevent bleeding, absorb the exudates, and provide a barrier against external contamination. Currently, in our hospital, after orthopedic surgery, traditional occlusive dressing of sterile gauze and non-woven hypoallergenic adhesive tape is placed. Some of the newest dressings have been shown to reduce the incidence of blisters compared with traditional dressing or colloid adhesive dressings. However, there are no comparative evaluations between the different types of dressings and their contribution to the overall results of the healing process. METHODS/DESIGN: This is a randomized, controlled, open-label trial to compare five types of dressings used in total knee and hip arthroplasty surgical wounds. A total of 550 patients will be randomly allocated to one of the following dressings: (1) traditional occlusive dressing, (2) Aquacel Surgical®, (3) Mepilex® Border Post-Op, (4) OpSite Post-Op Visible, or (5) UrgoTul® Absorb Border. The dressing assigned is placed right after surgery. Patients will be followed up to 14 days after surgery when the dressing is definitively removed and will be tracked up to 3 months to record any late complications. During the immediate postoperative period and patient hospitalization and at the ambulatory visits after discharge, every time that the dressing is changed, nurses perform the study assessments. The main study outcome will be the percentage of patients with skin integrity at all times when the dressing has been changed. Skin integrity is a composite of the absence of blisters, erosion, erythema, maceration, swelling, wound dehiscence, and purulent exudates. Secondary outcomes include time to first change of dressing; percentage of patients with presence/absence of blisters, erosion, erythema, maceration, swelling, wound dehiscence, and purulent exudates; number of dressing changes needed; days of hospital stay; and nurse and patient satisfaction. Differences in the main variable between each treatment group and group 1 will be tested by means of a chi-squared test or Fisher's exact test. Subgroup analyses of diabetic and non-diabetic patients, patients with a body mass index of more than 30 or not more than 30, and type of surgery (hip or knee) are planned. DISCUSSION: The results of this study will be useful for clinical decision making by giving information on the contribution of the dressings studied to the outcome of the wound and may also show which dressing offers better results depending on the characteristics of patients. TRIAL REGISTRATION: This trial has been registered at ClinicalTrials.gov ( NCT03190447 ). Retrospectively registered on 16 June 2017.
引用
- López-Parra M, Gil-Rey D, López-González E, et al. Open-label randomized controlled trial to compare wound dressings for patients undergoing hip and knee arthroplasty: study protocol for a randomized controlled trial. Trials. 2018. PMID: 29976227. doi:10.1186/s13063-018-2755-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。